In addition, both CD4+ and CD8+ T cell counts were lower in CT26/luc tumor-bearing mice (never), but not in the mirtazapine-treated, tumor-bearing mice (always, concurrent, and after) as compared with those of wild type and drug (Table 2). The gene discussed is DDX53; the disease is neoplasm.